(Total Views: 129)
Posted On: 03/02/2017 9:57:37 AM
Post# of 145362

$RGBP Regen BioPharma, Inc. Licenses NR2F6 Technology for Cancer Treatment and Autoimmune Disorders to CheckPoint Immunology Inc.
http://finance.yahoo.com/news/regen-biopharma...00603.html
http://finance.yahoo.com/news/regen-biopharma...00603.html

